Journal Highlight: Detection of Alzheimer's disease signature in MR images seven years before conversion to dementia: Toward an early individual prognosis

Skip to Navigation

Ezine

  • Published: Jan 18, 2016
  • Author: spectroscopyNOW
  • Channels: Chemometrics & Informatics
thumbnail image: Journal Highlight: Detection of Alzheimer's disease signature in MR images seven years before conversion to dementia: Toward an early individual prognosis
The performance of a new MR-based hippocampal grading score based on a pattern recognition strategy has been used to assess incident dementia in cognitively intact patients.

Detection of Alzheimer's disease signature in MR images seven years before conversion to dementia: Toward an early individual prognosis

Human Brain Mapping, 2015, 36, 4758–4770
Pierrick Coupé, Vladimir S. Fonov, Charlotte Bernard, Azar Zandifar, Simon F. Eskildsen, Catherine Helmer, José V. Manjón, Hélène Amieva, Jean-François Dartigues, Michèle Allard, Gwenaelle Catheline, D. Louis Collins and The Alzheimer's Disease Neuroimaging Initiative

Abstract: Finding very early biomarkers of Alzheimer's Disease (AD) to aid in individual prognosis is of major interest to accelerate the development of new therapies. Among the potential biomarkers, neurodegeneration measurements from MRI are considered as good candidates but have so far not been effective at the early stages of the pathology. Our objective is to investigate the efficiency of a new MR-based hippocampal grading score to detect incident dementia in cognitively intact patients. This new score is based on a pattern recognition strategy, providing a grading measure that reflects the similarity of the anatomical patterns of the subject under study with dataset composed of healthy subjects and patients with AD. Hippocampal grading was evaluated on subjects from the Three-City cohort, with a followup period of 12 years. Experiments demonstrate that hippocampal grading yields prediction accuracy up to 72.5% (P < 0.0001) 7 years before conversion to AD, better than both hippocampal volume (58.1%, P = 0.04) and MMSE score (56.9%, P = 0.08). The area under the ROC curve (AUC) supports the efficiency of imaging biomarkers with a gain of 8.4 percentage points for hippocampal grade (73.0%) over hippocampal volume (64.6%). Adaptation of the proposed framework to clinical score estimation is also presented. Compared with previous studies investigating new biomarkers for AD prediction over much shorter periods, the very long followup of the Three-City cohort demonstrates the important clinical potential of the proposed imaging biomarker. The high accuracy obtained with this new imaging biomarker paves the way for computer-based prognostic aides to help the clinician identify cognitively intact subjects that are at high risk to develop AD.

  • This paper is free to view for all users registered on spectroscopyNOW.com until the end of February 2016.
    After this time, you can purchase it using Pay-Per-View on Wiley Online Library.

Follow us on Twitter!

Social Links

Share This Links

Bookmark and Share

Microsites

Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2017 John Wiley & Sons, Inc. All Rights Reserved